Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(80.0%)
Early Phase 1
1(20.0%)
5Total
N/A(4)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06419231Not ApplicableCompleted

Effectiveness of a Butyrate Formulation and Butyrate + Polyphenol Formulation on Gut Health, Permeability and Associated Symptoms

Role: collaborator

NCT06501898Not ApplicableTerminated

Tributyrin: Time Course & Efficacy to Improve Health & Performance

Role: collaborator

NCT06219161Not ApplicableCompleted

The Acute Effect of a Theacrine-based Supplement on Mobilization of Various Stem Cell Populations.

Role: collaborator

NCT03937687Early Phase 1Completed

The Effects of a Combination of TeaCrine®, Dynamine, and Caffeine in Law Enforcement

Role: collaborator

NCT03231514Not ApplicableCompleted

Determining the Ergogenic Effects of Carb10™ Supplementation on Carbohydrate-Rich and Carbohydrate-Restricted Diets

Role: collaborator

All 5 trials loaded